Objectives To determine the prevalence and correlates of M ycoplasma genitalium (MG)
infection among men and women, determine the prevalence of gene mutations conferring …

Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …

Objectives To describe antibiotic use for treatment of Mycoplasma genitalium (MG) at an
urban sexual health centre in Australia. To describe MG positivity rates in those returning for …

Background Mycoplasma genitalium is a common sexually transmitted infection. Treatment
guidelines focus on those with symptoms and sexual contacts, generally with regimens …

Objective To estimate the prevalence of Mycoplasma genitalium in Toronto, Ont; detect
mutations associated with macrolide and fluoroquinolone resistance; and describe treatment …

Background. Mycoplasma genitalium (MG) is an emerging sexually transmitted infection
(STI) that is potentially associated with reproductive tract sequelae in women. This study …

Background While the contribution of Mycoplasma genitalium (MG) to symptoms in men is
well described, less is known about its association with common genital symptoms in …

Mycoplasma genitalium is a well-known cause of urethritis in men and has been associated
with cervicitis, pelvic inflammatory disease, and adverse obstetric outcomes in women. In …

Background Mycoplasma genitalium is an emerging sexually transmitted infection, with
increasing rates of resistance to fluroquinolones and macrolides, the recommended …

Objectives Resistance to both macrolides and fluoroquinolones has been reported in
Mycoplasma genitalium; however, due to limited diagnostics, studies are often small and …